Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.

Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the MT-5111 study in HER2-positive solid tumors is displayed, with its status, eligibility criteria, study locations, and trial details. Previously, the page showed a 403 Forbidden error.SummaryDifference58%

- Check12 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.2 to v3.8.0 while the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe ClinicalTrials.gov revision identifier in the footer changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site revision identifier in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision label updated to v3.7.0, replacing the previous v3.6.6. This appears to be a site-wide update and does not alter any study details or content on the page.SummaryDifference18%

- Check75 days agoChange DetectedFooter now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a small site update without changes to the study information displayed.SummaryDifference0.0%

Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.